RXQ Compounding LLC

FDA Regulatory Profile

RXQ Compounding LLC has 88 FDA recalls, 2 inspections, 0 510(k) clearances and 1 compliance action on record.

Latest recall
D-1689-2019 · Class II · Jun 19, 2019
Latest inspection
Aug 8, 2017 · OAI

Reviewing RXQ Compounding LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check RXQ Compounding LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls88Nov 2, 2026File dated Oct 27, 2026Current
510(k) clearances0Nov 2, 2026File dated Oct 30, 2026Current
Inspections2Nov 7, 2026Newest record Oct 28, 2026Current
Compliance actions1Nov 2, 2026Newest record Oct 29, 2026Current

Recent Recalls

NumberClassProductDate
D-1689-2019Class IINIACINAMIDE 100MG/ML, 10ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH…Jun 19, 2019
D-1695-2019Class IIPREDNISOLONE 1%, MOXIFLOXACIN 0.5% OPHTH SOL, 5ML per dropper bottle, RXQ Compounding, 340 West…Jun 19, 2019
D-1679-2019Class IIMETHYLCOBALAMIN (PFV) 10 MG/ML INJECTABLE, 10 ML per vial, RXQ Compounding, 340 West State Street…Jun 19, 2019
D-1686-2019Class IIMORPHINE 1MG/ML IN NACL 0.9% 55ML SYR (C-II), 55 ML per vial, RXQ Compounding, 340 West State…Jun 19, 2019
D-1657-2019Class IIEPINEPHrine 1:1000 INJECTION SOLUTION (PF) Syringe, 1 ML per syringe, RXQ Compounding, 340 West…Jun 19, 2019
D-1660-2019Class IIFOLIC ACID 10MG/ML INJECTION SOLUTION (MDV), 5 ML per vial, RXQ Compounding, 340 West State Street…Jun 19, 2019
D-1666-2019Class IIHYDROXOCOBALAMIN 1000 MCG/ML (PFV), 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9…Jun 19, 2019
D-1665-2019Class IIHYDROMORPHONE 0.2MG/ML IN NACL 0.9% SYR (C-II) , [a) 50 ML NDC 70731-0114-89; b) 55 ML NDC…Jun 19, 2019
D-1704-2019Class IISODIUM BICARBONATE 8.4% (1 MEQ/ML) INJ SOLN (PFV), 50 ML PER VIAL, RXQ Compounding, 340 West State…Jun 19, 2019
D-1719-2019Class IIZINC SULFATE 1MG/ML INJECTION SOLUTION, 30ML per VIAL, RXQ Compounding, 340 West State Street, Unit…Jun 19, 2019
D-1670-2019Class IIKETAMINE 10 MG/ML INJ SOL SYR (C-III), [a) 2 ML NDC: 70731-0132-02; b) 5 ML NDC: 70731-0132-05] per…Jun 19, 2019
D-1714-2019Class IITURBO DROPS (PHEN 10% / CYCLO 1%/ TROP 1%/ KETO 0.5%) OPHTH SOLN, 5 ML per dropper bottle, RXQ…Jun 19, 2019
D-1681-2019Class IIMIC B12 W/B6 (LIPOSTAT PLUS) 25/50/50/1/.175 MG/ML, 30 ML per vial, RXQ Compounding, 340 West State…Jun 19, 2019
D-1653-2019Class IIEDETATE DISODIUM 15% INJECTABLE, 100 ML per vial, RXQ Compounding, 340 West State Street, Unit 9…Jun 19, 2019
D-1676-2019Class IIMANGANESE SULFATE MONOHYDRATE (PFV) 0.1MG/ML INJ, 10 ML per syringe, RXQ Compounding, 340 West State…Jun 19, 2019
D-1662-2019Class IIGLUTATHIONE 200MG/ML (PFV) INJECTION SOLN, 10 ML per vial, RXQ Compounding, 340 West State Street…Jun 19, 2019
D-1716-2019Class IIVITAMIN B COMPLEX 100 (MDV), 30 ML per Vial, RXQ Compounding, 340 West State Street, Unit 9, Athens…Jun 19, 2019
D-1717-2019Class IIVITAMIN B COMPLEX 100 (PFV), [2 or 30 ML] per Vial, RXQ Compounding, 340 West State Street, Unit 9…Jun 19, 2019
D-1659-2019Class IIFENTANYL 2MCG/ML BUPIVACAINE 0.125% IN NACL 0.9% SRY C-II, 50ML per syringe (C-II) RXQ Compounding…Jun 19, 2019
D-1684-2019Class IIMITOMYCIN 0.04% (PF) OPH SOLN, 1ML per syringe, RXQ Compounding, 340 West State Street, Unit 9…Jun 19, 2019

Recent FDA Inspections

DateSiteProductClassificationFEI
Aug 8, 2017Albany, OHDrugsOfficial Action Indicated (OAI)3011509553
Sep 21, 2015Albany, OHDrugsOfficial Action Indicated (OAI)3011509553

NAI means no objectionable conditions or practices were found during the inspection. VAI means objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action. OAI means regulatory and/or administrative actions are recommended.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.